Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep 25:1:13.
doi: 10.1186/1750-1326-1-13.

ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients

Suzanne V Frankfort  1 , Valerie D Doodeman, Remco Bakker, Linda R Tulner, Jos P C M van Campen, Paul H M Smits, Jos H Beijnen
Affiliations

ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients

Suzanne V Frankfort et al. Mol Neurodegener. .

Abstract

Amyloid beta is an in vitro substrate for P-glycoprotein (P-gp), an efflux pump at the blood brain barrier (BBB). The Multi Drug Resistance (ABCB1) gene, encoding for P-gp, is highly polymorphic and this may result in a changed function of P-gp and may possibly interfere with the pathogenesis of Alzheimer's disease. This study investigates to what extent ABCB1 Single Nucleotide Polymorphisms (SNPs; C1236T in exon 12, G2677T/A in exon 21 and C3435T in exon 26) and inferred haplotypes exist in an elderly population and if these SNPs and haplotypes differ between patients with dementia and age-matched non-demented control patients. ABCB1 genotype, allele and haplotype frequencies were neither significantly different between patients with dementia and age-matched controls, nor between subgroups of different types of dementia nor age-matched controls. This study shows ABCB1 genotype frequencies to be comparable with described younger populations. To our knowledge this is the first study on ABCB1 genotypes in dementia. ABCB1 genotypes are presently not useful as a biomarker for dementia, as they were not significantly different between demented patients and age-matched control subjects.

PubMed Disclaimer

References

    1. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Del Rev. 2003;55:3–29. doi: 10.1016/S0169-409X(02)00169-2. - DOI - PubMed
    1. Borst P, Oude Elferink R. Mammalian ABC transporters in health and disease. Ann Rev Biochem. 2002;71:537–92. doi: 10.1146/annurev.biochem.71.102301.093055. - DOI - PubMed
    1. Lee G, Bendayan R. Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders. Pharm Res. 2004;21:1313–30. doi: 10.1023/B:PHAM.0000036905.82914.8e. - DOI - PubMed
    1. Marzolini C, Paus E, Buclin T, Kim RB. Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and clinical relevance. Clin Pharmacol Ther. 2004;75:13–33. doi: 10.1016/j.clpt.2003.09.012. - DOI - PubMed
    1. Bosch TM, Meijerman I, Beijnen JH, Schellens JH. Genetic polymorphisms of drug-metabolizing enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006;45:253–85. doi: 10.2165/00003088-200645030-00003. - DOI - PubMed

LinkOut - more resources